InSysBio to take part in BioTechX Europe 2025

events
Conference
September 25, 2025

InSysBio announces its participation in BioTechX Europe 2025 on 6–8 October 2025 at Messe Basel, Switzerland. Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, is going to present InSysBio's modeling services for drug research & development at the Booth S62. Moreover, Oleg will take part in the roundtable discussion "Integrating Artificial Intelligence with Quantitative Systems Pharmacology (QSP): Opportunities and Challenges".

Check out our Booth S62 at BioTechX Europe 2025!

About InSysBio

InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s cutting-edge QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry and innovative biotech companies. For more information about InSysBio, its solutions and services, visit www.insysbio.com

 

September 2018
MoTuWeThFrSaSu
     
1
2
3
4
5
6
7
8
9
10
11
1. 11 Sep 2018 15:30 InSysBio launches Alzheimer’s Disease Modeling Consortium InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, today announced the launch of Alzheimer’s Disease (AD) Modeling Consortium. The aim of the consortium is the support of drug development in AD by consolidation of efforts of teams from various pharmaceutical companies in framework of development and application of AD QSP platform.
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
1. 26 Sep 2018 15:36 InSysBio launches Immune Response Template online InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, today announced the launch of Immune Response Template (IRT) online. IRT is a QSP platform of human immune system and a tool for development of custom QSP models related to immune response.
27
28
29
30
Upcoming Events
18.10
InSysBio to participate in ACoP 2025
06.10
InSysBio to take part in BioTechX Europe 2025
06.10
InSysBio to announce participation in BioTechX Europe 2025 with focus on AI and QSP
Tags
Latest News
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"
05.08
InSysBio to launch Immune Response Template Open for QSP modeling
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha
18.06
InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology
03.06
InSysBio to present Integration of Cytocon DB and fIVE DB with Heta for QSP modeling